MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Total Liabilities (Quarterly): 140.41M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 140.41M |
June 30, 2024 | 139.67M |
March 31, 2024 | 122.72M |
December 31, 2023 | 121.92M |
September 30, 2023 | 117.89M |
June 30, 2023 | 115.89M |
March 31, 2023 | 113.14M |
December 31, 2022 | 109.82M |
September 30, 2022 | 101.10M |
June 30, 2022 | 28.75M |
December 31, 2021 | 28.17M |
June 30, 2021 | 24.88M |
June 30, 2021 | 24.88M |
December 31, 2020 | 26.01M |
June 30, 2020 | 19.13M |
June 30, 2020 | 19.13M |
December 31, 2019 | 20.90M |
June 30, 2019 | 11.25M |
June 30, 2019 | 11.25M |
December 31, 2018 | 13.36M |
June 30, 2018 | 13.56M |
June 30, 2018 | 13.56M |
December 31, 2017 | 14.98M |
Date | Value |
---|---|
June 30, 2017 | 11.49M |
June 30, 2017 | 11.49M |
December 31, 2016 | 14.98M |
June 30, 2016 | 12.95M |
June 30, 2016 | 12.95M |
December 31, 2015 | 13.48M |
June 30, 2015 | 6.982M |
June 30, 2015 | 6.982M |
December 31, 2014 | 7.177M |
June 30, 2014 | 4.88M |
June 30, 2014 | 4.88M |
December 31, 2013 | 4.847M |
June 30, 2013 | 4.302M |
June 30, 2013 | 4.302M |
December 31, 2012 | 3.967M |
June 30, 2012 | 4.365M |
June 30, 2012 | 4.365M |
December 31, 2011 | 4.363M |
June 30, 2011 | 5.063M |
December 31, 2010 | 4.916M |
June 30, 2010 | 5.778M |
December 31, 2009 | 8.528M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.13M
Minimum
Jun 2020
140.41M
Maximum
Sep 2024
74.97M
Average
101.10M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
Galapagos NV | 1.463B |
UCB SA | 7.156B |
Mithra Pharmaceuticals SA | 416.74M |
Nyxoah SA | 42.51M |
Celyad Oncology SA | 12.13M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 157.41M |
Shareholders Equity (Quarterly) | 16.99M |
Debt to Equity Ratio | 3.022 |
Current Ratio | 1.541 |
Net Debt Paydown Yield | -3.16% |